Takeda eyeing an acquisition in India?
This article was originally published in Scrip
Executive Summary
Months after announcing that it will acquire Nycomed for €9.6 billion, there is speculation that Japan's largest drugs firm, Takeda, may be trying to play catch up with its peers in India through an investment in a local company.